Talphera, Inc.

TLPH Healthcare Drug Manufacturers Specialty & Generic

In the quarter to June 2026, revenue fell 99.6%, EPS grew 40.0% and free cash flow fell 33.1%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years; insiders bought in the last twelve months.

1.08 0.01 +0.93%
Market cap
$55.5M
P/E
0.0×
Fwd P/E
−3.1×
Dividend yield
—
F-score
n/a
Altman Z
−20.73
Beneish M
n/a
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.34 0.00 — 0.00
Piotroski F-Score
1 2 4 1 4 4 3 4 — —
P/S ratio
6.66 12.02 62.73 72.99 19.52 23.82 9.26 11.69 — 113.49
Altman Z-Score
(2.71) (5.80) (3.35) (6.52) (10.17) (9.15) (13.61) (31.77) — (20.73)
Altman Z″-Score (non-manufacturers)
(5.06) (12.32) (6.27) (14.35) (23.31) (20.56) (30.43) (71.94) — (49.59)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00
Beneish M-Score
(1.19) — — — — — — — — —
P/Operating CF
(11.20) (14.40) (15.01) (11.80) (16.71) (8.39) (3.03) (2.67) — (19.85)
P/B ratio
0.00 0.00 31.73 0.00 0.00 0.00 0.75 0.75 — 2.84
EV/Sales
3.27 6.85 19.16 55.08 15.64 12.17 2.27 8.34 — 80.58
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00
EV/FCF
(1.71) (1.70) (1.38) (2.31) (2.10) (1.08) (0.13) (0.51) — (3.93)
Current Ratio
8.74 4.64 6.78 5.27 2.66 2.73 1.78 2.57 3.56 5.49
Net Debt/EBITDA
1.96 1.12 2.67 0.78 0.54 0.97 0.65 0.57 0.58 1.50
Debt/Equity
(4.04) (0.52) 2.82 (0.61) (0.39) (0.38) 0.25 0.00 0.00 0.00
ROE
(310.75%) 246.18% 292.34% 286.51% 83.11% 76.60% (601.31%) (102.44%) (117.65%) (114.16%)
ROA
(37.89%) (58.68%) (48.09%) (50.25%) (51.23%) (48.69%) 67.52% (54.20%) (67.32%) (59.60%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (246.80%) (223.45%) 0.00% 0.00%
Return on Tangible Assets
(48.18%) (84.71%) (45.53%) (73.30%) (90.02%) (73.26%) 392.08% (260.43%) (192.08%) (83.61%)
Average Days of Receivables
122.66 69.99 68.05 68.89 42.79 20.72 0.00 0.00 — 0.00
Earnings Yield
(36.86%) (54.15%) (35.50%) (31.75%) (38.71%) (51.79%) 290.99% (200.00%) — (32.46%)
Free Cash Flow Yield
(28.66%) (33.47%) (22.16%) (32.71%) (38.18%) (47.42%) (185.32%) (140.87%) — (18.08%)
Free Cash Flow per Share
(14.62) (13.72) (10.24) (13.80) (9.47) (5.31) (4.11) (1.04) (0.49) (0.27)
Book value per Share
(2.36) (15.57) 1.46 (10.46) (13.08) (5.99) 2.95 0.99 0.31 0.40
Free Cash Flow
(33.11) (32.17) (29.89) (54.65) (40.36) (31.83) (30.38) (14.87) (12.68) (11.36)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00
Other line items

Show all line items

Columns are period end dates